PerkinElmer Elects Michel Vounatsos to its Board of Directors
Summary
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Michel Vounatsos has been elected to its board of directors, effective March 1, 2020. Mr. Vounatsos also developed and instituted a strategic framework for enhancing Merck’s relationships with key constituents, including providers, payers and retailers and governmental bodies throughout the world. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally.
Classifications
AskAI Classifications
LabelsLinked Companies
